Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nursery places for three-year-olds: introduction of free entitlement did not deliver long-term benefits for children?s development, new research finds

  • Boosting use of multi-sensory environments in dementia care

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • Exposure therapy appears helpful in treating patients with prolonged grief

  • Omega 3 can help children with ADD, experts say

  • Music therapy reduces depression in children, adolescents

  • Teens whose parents exert more psychological control have trouble with closeness, independence

  • Two days later: Adolescents' conflicts with family spill over to school, vice versa

  • If you're over 60, drink up: Alcohol associated with better memory

  • A new tune: There is intonation in sign language too

  •